HuGE Literature Finder
Records
1
-
18
| Predicting the prognosis of hepatocellular carcinoma based on the interaction between pyroptosis, apoptosis, and necroptosis. Clinical and experimental medicine 2022 Oct . Qian Fang, Kong Wei, Wang Shuaiqun, Wei K |
| Integrative study of EZH2 mutational status, copy number, protein expression and H3K27 trimethylation in AML/MDS patients. Clinical epigenetics 2021 Apr 13 (1): 77. Stomper Julia, Meier Ruth, Ma Tobias, Pfeifer Dietmar, Ihorst Gabriele, Blagitko-Dorfs Nadja, Greve Gabriele, Zimmer Dennis, Platzbecker Uwe, Hagemeijer Anne, Schmitt-Graeff Ingrid, Lübbert Micha |
| Genomic analysis of primary and secondary myelofibrosis redefines the prognostic impact of ASXL1 mutations: a FIM study. Blood advances 2021 Mar 5 (5): 1442-1451. Luque Paz Damien, Riou Jérémie, Verger Emmanuelle, Cassinat Bruno, Chauveau Aurélie, Ianotto Jean-Christophe, Dupriez Brigitte, Boyer Françoise, Renard Maxime, Mansier Olivier, Murati Anne, Rey Jérôme, Etienne Gabriel, Mansat-De Mas Véronique, Tavitian Suzanne, Nibourel Olivier, Girault Stéphane, Le Bris Yannick, Girodon François, Ranta Dana, Chomel Jean-Claude, Cony-Makhoul Pascale, Sujobert Pierre, Robles Margot, Ben Abdelali Raouf, Kosmider Olivier, Cottin Laurane, Roy Lydia, Sloma Ivan, Vacheret Fabienne, Wemeau Mathieu, Mossuz Pascal, Slama Borhane, Cussac Vincent, Denis Guillaume, Walter-Petrich Anouk, Burroni Barbara, Jézéquel Nathalie, Giraudier Stéphane, Lippert Eric, Socié Gérard, Kiladjian Jean-Jacques, Ugo Valér |
| Identification and Validation a Necroptosis?related Prognostic Signature and Associated Regulatory Axis in Stomach Adenocarcinoma. OncoTargets and therapy 2021 12 14 5373-5383. Wang Ning, Liu Dingshe |
| M7-FLIPI is not prognostic in follicular lymphoma patients with first-line rituximab chemo-free therapy. British journal of haematology 2019 Aug . Lockmer Sandra, Ren Weicheng, Brodtkorb Marianne, Østenstad Bjørn, Wahlin Björn E, Pan-Hammarström Qiang, Kimby E |
| Brainstem biopsy in pediatric diffuse intrinsic pontine glioma in the era of precision medicine: the INFORM study experience. European journal of cancer (Oxford, England : 1990) 2019 4 114 27-35. Pfaff Elke, El Damaty Ahmed, Balasubramanian Gnana Prakash, Blattner-Johnson Mirjam, Worst Barbara C, Stark Sebastian, Witt Hendrik, Pajtler Kristian W, van Tilburg Cornelis M, Witt Ruth, Milde Till, Jakobs Martin, Fiesel Petra, Frühwald Michael C, Hernáiz Driever Pablo, Thomale Ulrich W, Schuhmann Martin U, Metzler Markus, Bochennek Konrad, Simon Thorsten, Dürken Matthias, Karremann Michael, Knirsch Stephanie, Ebinger Martin, von Bueren André O, Pietsch Torsten, Herold-Mende Christel, Reuss David E, Kiening Karl, Lichter Peter, Eggert Angelika, Kramm Christof M, Pfister Stefan M, Jones David T W, Bächli Heidi, Witt Ol |
| In vivo CRISPR screening unveils histone demethylase UTX as an important epigenetic regulator in lung tumorigenesis. Proceedings of the National Academy of Sciences of the United States of America 2018 4 115 (17): E3978-E3986. Wu Qibiao, Tian Yahui, Zhang Jian, Tong Xinyuan, Huang Hsinyi, Li Shuai, Zhao Hong, Tang Ying, Yuan Chongze, Wang Kun, Fang Zhaoyuan, Gao Lei, Hu Xin, Li Fuming, Qin Zhen, Yao Shun, Chen Ting, Chen Haiquan, Zhang Gong, Liu Wanting, Sun Yihua, Chen Luonan, Wong Kwok-Kin, Ge Kai, Chen Liang, Ji Hongb |
| A missense variant in EZH2 is associated with colorectal cancer risk in a Chinese population. Oncotarget 2017 Nov 8 (55): 94738-94742. Li Huihui, Chang Chunxiao, Shang Yuhong, Qiang Ling, Zhang Baoxuan, Bu Bing, Ren Guohua, Song Lihua, Shang Mao, Yu Jinmi |
| Epigenetic silencing and activation of transcription: influence on the radiation sensitivity of glioma cell lines. International journal of radiation biology 2017 1 93 (5): 494-506. Sak Ali, Kübler Dennis, Bannik Kristina, Groneberg Michael, Strunz Sonja, Kriehuber Ralf, Stuschke Mart |
| Impact of genotype on leukaemic transformation in polycythaemia vera and essential thrombocythaemia. British journal of haematology 2017 09 178 (5): 764-771. Alvarez-Larrán Alberto, Senín Alicia, Fernández-Rodríguez Concepción, Pereira Arturo, Arellano-Rodrigo Eduardo, Gómez Montse, Ferrer-Marin Francisca, Martínez-López Joaquín, Camacho Laura, Colomer Dolors, Angona Anna, Navarro Blanca, Cervantes Francisco, Besses Carlos, Bellosillo Beatriz, Hernández-Boluda Juan Carl |
| Integration of gene mutations in risk prognostication for patients receiving first-line immunochemotherapy for follicular lymphoma: a retrospective analysis of a prospective clinical trial and validation in a population-based registry. The Lancet. Oncology 2015 Sep 16 (9): 1111-22. Pastore Alessandro, Jurinovic Vindi, Kridel Robert, Hoster Eva, Staiger Annette M, Szczepanowski Monika, Pott Christiane, Kopp Nadja, Murakami Mark, Horn Heike, Leich Ellen, Moccia Alden A, Mottok Anja, Sunkavalli Ashwini, Van Hummelen Paul, Ducar Matthew, Ennishi Daisuke, Shulha Hennady P, Hother Christoffer, Connors Joseph M, Sehn Laurie H, Dreyling Martin, Neuberg Donna, Möller Peter, Feller Alfred C, Hansmann Martin L, Stein Harald, Rosenwald Andreas, Ott German, Klapper Wolfram, Unterhalt Michael, Hiddemann Wolfgang, Gascoyne Randy D, Weinstock David M, Weigert Oliv |
| Incidences and Prognostic Impact of c-KIT, WT1, CEBPA, and CBL Mutations, and Mutations Associated With Epigenetic Modification in Core Binding Factor Acute Myeloid Leukemia: A Multicenter Study in a Korean Population. Annals of laboratory medicine 2015 May 35 (3): 288-97. Park Sang Hyuk, Lee Hyun Ji, Kim In-Suk, Kang Jeong-Eun, Lee Eun Yup, Kim Hyeoung-Joon, Kim Yeo-Kyeoung, Won Jong-Ho, Bang Soo Mee, Kim Hawk, Song Moo-Kon, Chung Joo Seop, Shin Ho-J |
| Impact of mutational status on outcomes in myelofibrosis patients treated with ruxolitinib in the COMFORT-II study. Blood 2014 Apr 123 (14): 2157-60. Guglielmelli Paola, Biamonte Flavia, Rotunno Giada, Artusi Valentina, Artuso Lucia, Bernardis Isabella, Tenedini Elena, Pieri Lisa, Paoli Chiara, Mannarelli Carmela, Fjerza Rajmonda, Rumi Elisa, Stalbovskaya Viktoriya, Squires Matthew, Cazzola Mario, Manfredini Rossella, Harrison Claire, Tagliafico Enrico, Vannucchi Alessandro M, , |
| Epigenetic silencing of ARNTL, a circadian gene and potential tumor suppressor in ovarian cancer. International journal of oncology 2014 9 45 (5): 2101-7. Yeh Chia-Ming, Shay Jacqueline, Zeng Ting-Chuan, Chou Jian-Liang, Huang Tim H-M, Lai Hung-Cheng, Chan Michael W |
| EZH2-induced H3K27me3 is associated with epigenetic repression of the ARHI tumor-suppressor gene in ovarian cancer. Cell biochemistry and biophysics 2014 8 71 (1): 105-12. Fu Yibing, Chen Jing, Pang Bo, Li Chunyan, Zhao Jing, Shen Ke |
| Histone-modifying genes as biomarkers in hepatocellular carcinoma. International journal of clinical and experimental pathology 2014 6 7 (5): 2496-507. Hung Shih-Ya, Lin Hui-Hua, Yeh Kun-Tu, Chang Jan-Gow |
| Mutations and prognosis in primary myelofibrosis. Leukemia 2013 Sep 27 (9): 1861-9. Vannucchi A M, Lasho T L, Guglielmelli P, Biamonte F, Pardanani A, Pereira A, Finke C, Score J, Gangat N, Mannarelli C, Ketterling R P, Rotunno G, Knudson R A, Susini M C, Laborde R R, Spolverini A, Pancrazzi A, Pieri L, Manfredini R, Tagliafico E, Zini R, Jones A, Zoi K, Reiter A, Duncombe A, Pietra D, Rumi E, Cervantes F, Barosi G, Cazzola M, Cross N C P, Tefferi |
| Clinical effect of point mutations in myelodysplastic syndromes. The New England journal of medicine 2011 Jun 364 (26): 2496-506. Bejar Rafael, Stevenson Kristen, Abdel-Wahab Omar, Galili Naomi, Nilsson Björn, Garcia-Manero Guillermo, Kantarjian Hagop, Raza Azra, Levine Ross L, Neuberg Donna, Ebert Benjamin |
- Page last reviewed:Feb 1, 2023
- Page last updated:Mar 31, 2023
- Content source: